by NCCF Staff | Mar 24, 2021 | Canine Cancer Blog
Hemangiosarcoma (HSA) is one of the most aggressive cancers out there with a very low survival rate by the time it is detected in our dogs. Hemangiosarcoma treatments in dogs have previously only extended the life of a dog few months. That’s the reason NCCF has funded...
by Sara Nice | Feb 3, 2020 | Canine Cancer Blog, Founder Writings
My Super Bowl enjoyment has always been in the commercials, not so much in the game. In the past several years, my interest in the commercials has diminished because there just have not been quite as many good ones as their used to be. As the big game approached, I...
by Sara Nice | Oct 10, 2019 | Canine Cancer Blog, Founder Writings
Ever since the socks have come into the office my kids have had their eye on them and finally the day came that they could wear them. Their school was holding the annual Blessing of the Animals. The kids are always so proud of their Finn and they love being able to...
by NCCF Editor | Aug 24, 2018 | Canine Cancer Blog
Doctors at the Lois Bates Acheson Veterinary Teaching Hospital (part of the Carlson College of Veterinary Medicine at Oregon State University) are testing a new treatment for mammary cancer in dogs, involving nanoparticles designed to cling to cancerous cells once...
by NCCF Editor | Jun 21, 2018 | Canine Cancer Blog
Josie, a terrier mix from Owings Mills, Md., was the first dog to survive a clinical trial at Johns Hopkins Hospital aimed at finding a treatment for hemangiosarcoma, one of the most deadly cancers for pets. Josie was diagnosed in December 2017 with cancer in the...
Recent Comments